Mirtazapine

Synonyms: Org3770,6-Azamianserin

Mirtazapine (Org3770,6-Azamianserin) is an adrenergic and seroton receptor antagonist, used to treat depression.

Mirtazapine Chemical Structure

Mirtazapine Chemical Structure

CAS No. 85650-52-8

Purity & Quality Control

Batch: S201601 DMSO]53 mg/mL]false]Ethanol]53 mg/mL]false]Water]Insoluble]false Purity: 99.99%
99.99

Mirtazapine Related Products

Biological Activity

Description Mirtazapine (Org3770,6-Azamianserin) is an adrenergic and seroton receptor antagonist, used to treat depression.
Targets
5-HT [1]
In vitro
In vitro

Mirtazapine displays marked affinity for cloned, human alpha2A-adrenergic (AR) receptors at which it blocks noradrenaline (NA)-induced stimulation of guanosine-5'-O-(3-[35S]thio)-triphosphate ([35S]-GTPgammaS) binding. Mirtazapine shows high affinity for cloned, human serotonin (5-HT)2C receptors at which it abolishes 5-HT-induced phosphoinositide generation. Mirtazapine markedly elevates dialysate levels of NA and, in FCX, DA, whereas 5-HT is not affected.[1] Mirtazapine enhances the effectiveness of the electrical stimulation of the ascending 5-HT pathway by blocking both alpha-2 adrenergic auto- and heteroreceptors. Mirtazapine blocks the suppressant effect of microiontophoretically applied norepinephrine (NE) on the firing activity of CA3 dorsal hippocampus pyramidal neurons, indicating their antagonistic effects on postsynaptic alpha-2 adrenoceptors. [2]

In Vivo
In vivo

Mirtazapine (10-250 mg/kg i.v.) enhances dose-dependently the firing activity of the 5-HT neurons in naive rats, but not in 6-hydroxydopamine-pretreated rats. [2] Mirtazapine (5 mg/kg/day, s.c., using osmotic minipumps) increases the spontaneous firing activity of locus coeruleus noradrenaline (NA) neurons in male Sprague-Dawley rats. Mirtazapine antagonizes both the enhancing effect of a low dose (10 mg/kg, i.v.) and the reducing effect of a high dose (100 mg/kg, i.v.) of the alpha 2-adrenoceptor agonist clonidine on the effectiveness of the electrical stimulation of the ascending 5-HT pathway in suppressing the firing activity of dorsal hippocampus CA3 pyramidal neurons. [3] Mirtazapine (5 mg/kg s.c.) only slightly affects DOPAC and homovanillic acid levels in the striatum, hardly affects 5-HT release in freely moving rats, but clearly increased 5-hydroxyindole acetic acid. [4]

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05452174 Terminated
Pregnancy|Severe Nausea and Vomiting|Hyperemesis Gravidarum
Northwestern University|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
June 13 2022 Phase 1|Phase 2
NCT04614584 Recruiting
Methamphetamine Use Disorder|Drug Interaction|Cardiovascular Abnormalities
San Francisco Department of Public Health|University of California Los Angeles
July 12 2021 Phase 1
NCT03785691 Terminated
Hyperemesis Gravidarum|Nausea Gravidarum|Vomiting of Pregnancy
Nordsjaellands Hospital|Bispebjerg Hospital|Aarhus University Hospital|Herlev and Gentofte Hospital|Hvidovre University Hospital|Odense University Hospital|Rigshospitalet Denmark|Regionernes Medicinpulje|Kolding Sygehus
March 1 2019 Phase 2
NCT03935685 Recruiting
Glioma of Brain
University of California Irvine
February 26 2019 Phase 2

Chemical Information & Solubility

Molecular Weight 265.35 Formula

C17H19N3

CAS No. 85650-52-8 SDF Download Mirtazapine SDF
Smiles CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 53 mg/mL ( (199.73 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 53 mg/mL

Water : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Mirtazapine | Mirtazapine ic50 | Mirtazapine price | Mirtazapine cost | Mirtazapine solubility dmso | Mirtazapine purchase | Mirtazapine manufacturer | Mirtazapine research buy | Mirtazapine order | Mirtazapine mouse | Mirtazapine chemical structure | Mirtazapine mw | Mirtazapine molecular weight | Mirtazapine datasheet | Mirtazapine supplier | Mirtazapine in vitro | Mirtazapine cell line | Mirtazapine concentration | Mirtazapine nmr